King's College London
United Kingdom
History
The European Commission has strongly supported research in preventing mental disorders and promoting good mental health, notably across all ages and across different types of mental disorders, and additional programmes of research are expected. The ECNP PMD-MHP Network was set up to address these gaps in knowledge and is highly strategic for the ECNP, as it aligns with the European Commission’s ROAMER (A Roadmap for Mental Health Research in Europe). The PMD-MHP is highly multidisciplinary, including basic researchers, psychiatrists, psychologists and neuroscientists.
The ECNP PMD-MHP Network has advanced preventive psychiatry in recent years in determining key aspects of good mental health, key intervention strategies to improve them, as well as effective preventive interventions. Through the Collaborative Outcomes study on Health and Functioning during Infection Times (CoH-FIT) study, we have produced the largest prospective study assessing the mental health impacts of the COVID-19 pandemic worldwide. In collaboration with the ECNP Bipolar Network and EBRA, we have led workshops to understand how best to implement precision and preventive psychiatry in Europe with input from key stakeholders, including researchers, clinicians, experts-by-experience, industry and policymakers. We look forward to further advancing the field to improve prevention of mental disorders and promote good mental health across Europe.
Goals
1
Facilitate multidisciplinary collaboration, knowledge and data sharing building on existing ECNP Networks to support innovative translational research for the benefit of patients, focusing on the transdiagnostic disease-modifying prevention of mental disorders.
2
Standardise core assessment, outcome measures and interventional research strategies for the promotion of mental health in Europe.
3
Promote clinical research partnerships across disciplines and sectors, including public-private partnerships, in particular with pharmaceutical industries, charities and the public.
4
Apply for European grant funding and produce research reports to disseminate the findings of the PMD-MHP Network in international journals.
Members
| Member name | Institution | City | Country |
| Michael Bauer | Dresden University of Technology | Dresden | Germany |
| Andreas Bechdolf | Vivantes Klinikum am Urban | Berlin | Germany |
| Stefan Borgwardt | University of Basel | Basel | Switzerland |
| Ana Catalan | Hospital Basurto | Bilbao | Spain |
| Simon Cervenka | Uppsala University | Uppsala | Sweden |
| Christoph U. Correll | Charité – Universitätsmedizin Berlin | Berlin | Germany |
| Kim Q. Do | Lausanne University Hospital | Lausanne | Switzerland |
| Katharina Domschke | University of Freiburg | Freiburg | Germany |
| Silvana Galderisi | University of Campania "Luigi Vanvitelli" | Naples | Italy |
| Lars Kessing | Rigshospitalet | Copenhagen | Denmark |
| Nikolaos Koutsouleris | Ludwig Maximilian University of Munich | Munich | Germany |
| Marie-Odile Krebs | Centre Hospitalier Sainte-Anne | Paris | France |
| Philip McGuire | King's College London | London | United Kingdom |
| Nadja P. Marić | Institute of Mental Health | Belgrade | Serbia |
| Andreas Meyer-Lindenberg | University of Heidelberg | Mannheim | Germany |
| Mark Millan | Servier Research Institute | Croissy-sur-Seine | France |
| Trine Munk-Olsen | University of Southern Denmark | Odense | Denmark |
| Andrea Pfennig | University Hospital Carl Gustav Carus | Dresden | Germany |
| Michael Sand | Boehringer-Ingelheim | Ridgefield | USA |
| Marco Solmi | University of Padova | Padova | Italy |
| Gisela Sugranyes | Clinical Institute of Neuroscience | Barcelona | Spain |
| Therese van Amelsvoort | Maastricht University | Maastricht | The Netherlands |
| Eduard Vieta | Clinical Institute of Neuroscience | Barcelona | Spain |
Early Career Academy member
| Member name | Institution | City | Country |
| Claudia Aymerich Nicolas | Hospital Universitario Basurto | Bilbao | Spain |
Publications
-
2020Fusar-Poli et al.
What is good mental health? A scoping review
European Neuropsychopharmacology -
2020Fusar-Poli et al.
Prevention of psychosis: advances in detection, prognosis, and intervention
JAMA Psychiatry -
2019Fusar-Poli et al.
European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP)
European Neuropsychopharmacology -
2022Fusar-Poli et al.
Ethical considerations for precision psychiatry: A roadmap for research and clinical practice.
European Neuropsychopharmacology -
2020de Pablo et al.
Universal and selective interventions to promote good mental health in young people: Systematic review and meta-analysis.
European Neuropsychopharmacology -
2021de Pablo et al.
Universal and Selective Interventions to Prevent Poor Mental Health Outcomes in Young People: Systematic Review and Meta-analysis
Harvard review of psychiatry
Research projects
CoH-FIT
Research study assessing mental health measures relating to the COVID-19 pandemic.
Grant agreement No. not found
ePreventPsych
Implementing digital precision psychiatry tools across EU sites.
Funding from Vinnova: SEK 4 500 000
PSMD
The PMD-MHP and the Bipolar Disorders Networks created the Prevention of Severe Mental Disorders (PSMD) cluster recognised by the project EBRA (European Brain Research Agenda).
Grant agreement No. 825348
Events
CAARMS training
13-14 April, 12 May, 12 June 2026 in Utrecht, The Netherlands
Training for healthcare providers in assessing the clinical high risk for psychosis states.